Assertio Holdings, Inc. (ASRT)
12.02
-0.72
(-5.65%)
USD |
NASDAQ |
Feb 09, 16:00
12.06
+0.04
(+0.37%)
After-Hours: 20:00
Assertio Holdings EPS Diluted (Quarterly) : 1.612 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Harrow, Inc. | 0.0262 |
| Altimmune, Inc. | -0.2126 |
| Verastem, Inc. | -1.347 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
| Ultragenyx Pharmaceutical, Inc. | -1.808 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.44M |
| Revenue (Quarterly) | 49.46M |
| Total Expenses (Quarterly) | 38.01M |
| Enterprise Value | 28.67M |
| Gross Profit Margin (Quarterly) | 61.01% |
| Profit Margin (Quarterly) | 23.14% |
| Earnings Yield | -22.72% |
| Normalized Earnings Yield | -17.26 |